eResearchTechnology Inc.

Dr. McKelvey has served as ERT’s president and chief executive officer since June 2006. Prior to that, he was employed by PAREXEL International, one of the largest biopharmaceutical outsourcing organizations in the world, where he served as corporate senior vice president, clinical research services (CRS). He was responsible for the CRS Americas clinical operations in addition to being in charge of the worldwide data management, biostatistics and programming activities for CRS. Before his work at PAREXEL, Dr. McKelvey owned and operated his own firm, McKelvey LLC, which provided strategic consulting for organizations on e-business strategy, product development and marketing. He also spent six years with ICF Consulting as executive vice president and president - ICF Information Technology, Inc. In 1999, he participated in the management-led buyout of ICF Consulting from its then-parent ICF Kaiser International. Dr. McKelvey also served DRI/McGraw-Hill for 10 years in a variety of executive roles in the technology consulting and information management areas. He spent the first 10 years of his career with the U.S. Department of Commerce, where he served as forecast manager and senior economist in the Bureau of Economic Analysis. Dr. McKelvey holds an M.A. and Ph.D. from the Wharton School, University of Pennsylvania and an A.B. degree from Williams College.

David D. Gathman, who will not be standing for reelection at the annual meeting, has served as a director since 2003. The governance and nominating committee determined not to nominate him for a new term due to his recent relocation to Florida and the demands of his position as Chief Financial Officer of SunGard Public Sector Group, Inc. The governance and nominating committee concluded that the interests of the stockholders would be appropriately represented by a board consisting of eight members and, as a result, at the governance and nominating committee s recommendation, the board of directors decided at its meeting on December 9, 2008 not to nominate Mr. Gathman for a new term and to reduce the number of directors from nine to eight effective at the annual meeting.

Dr. Litwin is a board-certified cardiologist and internist and has served as ERT’s executive vice president and chief medical officer since December 2005. Beginning in 2000, he served as our senior vice president and chief medical officer. Previously, Dr. Litwin was employed by Executive Health Group, a leading international provider of physical examinations for corporate executives, from May 1993 to July 2000, most recently as executive vice president and chief operating officer. Dr. Litwin also served as a consultant for Schlumberger, Ltd. from March 1996 to July 2000 and for the American and National League of Professional Baseball Clubs from April 1995 to March 1999.

Dr. Morganroth has served as the chairman of ERT’s Board of Directors since 1999 and as a member of our Board of Directors since 1997. He has served as our chief scientific officer since April 2006. Prior to that, he served as our chief scientist from March 2001 to December 2005 and as our chief executive officer from 1993 to March 2001. In addition, Dr. Morganroth has consulted for ERT since 1977. Dr. Morganroth is a globally recognized cardiologist and clinical researcher. He served for more than 10 years as a medical review officer/expert for the U.S. Food and Drug Administration (FDA).

Mr. Devine has served as ERT’s executive vice president and chief development officer since December 2005. Prior to that, he served since 2003 as senior vice president and chief development officer, and since 2002 as vice president, research and development. Mr. Devine was previously employed by ecHUB as chief technology officer from 2000 to 2002. He also spent 18 years at IBM and Lockheed Martin in senior-director level technology positions.

Ms. Furlong has served as ERT’s executive vice president, cardiac safety operations since December 2005. Earlier, she served as our senior vice president, regulatory compliance since January 2004. From February 2001 to January 2004, Ms. Furlong served as our vice president, regulatory compliance, and from February 1999 to February 2001, she served as our senior director, regulatory compliance. Ms. Furlong has been employed with ERT for 12 years.

Mr. Blakeley has been ERT's executive vice president, sales and marketing since 2007. He previously served as our senior vice president, international operations and sales beginning September 2006. He also served as our group vice president, international business development from January 2005 to August 2006 and as our director of business development from May 2002 to December 2004. Prior to joining ERT, Mr. Blakeley was managing director of MediServe Medical UK Limited, a medical devices specialist.

David Laky has spent the last 17 years implementing technology solutions within regulated environments including financial organisations, government agencies, and life sciences companies. Dave has worked at eResearchTechnology (eRT), Inc for eight years and is currently the Senior Vice President of their EXPeRT eClinical division. Dave’s responsibilities involve managing the operations for the successful deployment of eRT’s eClinical products on a global basis, as well as directing the evolution of the product line for future releases. Dave graduated with a BS in Accounting and a minor in Economics from The Pennsylvania State University

Mr. Tiger has been ERT’s senior vice president, Americas sales since October 2006. He also served as our senior vice president, international sales and operations from October 2005 to September 2006; senior vice president, international operations from July 2004 to October 2005; vice president, international business development from August 2002 to July 2004; and as director of business development from January 2001 to August 2002.

Dr. Faich has served on our board of directors since 2004. Dr. Faich has served as Senior Vice President of UBC Epidemiology and Risk Management since June 2005. He served as the President of Pharmaceutical Safety Assessments, a consulting firm, from 1994 until June 2005. Dr. Faich co-chaired the original CIOMS International Adverse Reaction Working Group and was a founding board member of the International Society of Pharmacoepidemiology. Dr. Faich is a Fellow of the American Colleges of Physicians, Preventive Medicine and Epidemiology and has authored over 90 scientific papers and received numerous awards. He is currently an Adjunct Scholar for the Center for Clinical Epidemiology at the University of Pennsylvania.

Mr. Brown has been ERT’s senior vice president, strategic marketing, planning and partnerships since September 2006. Prior to this, Mr. Brown served as our senior vice president, outsourcing partnerships from July 2002 to August 2006. From January 2000 to June 2002, Mr. Brown was our senior vice president, cardiac safety. Mr. Brown has been employed with us for over 26 years.

Ms. Mattern joined ERT in April 2007 as vice president, human resources. Prior to ERT, she was manager of human resources at Subaru of America and vice president of human resources at Greater Atlantic HMO.

Mr. DeMane has served on our board of directors since July 2008. Effective April 2009, Mr. DeMane will serve as Senior Advisor with Thomas, McNerney & Partners, a health care venture capital firm. Mr. DeMane served as Chief Operating Officer of Medtronic, Inc. from August 2007 to April 2008. Prior to that, Mr. DeMane served Medtronic as Senior Vice President from May 2007 to August 2007, Senior Vice President and President of Europe, Canada, Latin America and Emerging Markets from August 2005 to May 2007 and Senior Vice President and President, Spinal, ENT and Navigation from February 2002 to August 2005.

Sheldon M. Bonovitz, 70, has served as a director since November 2002. Prior to November 2002, he served as a director of our predecessor for more than five years. Mr. Bonovitz has been a partner with the law firm of Duane Morris LLP for more than five years and is currently Chairman and Chief Executive Officer of that firm. Mr. Bonovitz is also a director of eResearch Technology, Inc. In addition, he is a trustee of the Dolfinger-McMahon Charitable Trust and the Christian R. and Mary F. Lindbach Foundation, and he serves on the Board of Trustees of The Curtis Institute of Music and the Philadelphia Museum of Art. Mr. Bonovitz is married to a first cousin of Mr. Brian L. Roberts.

Mr. Phillips has served on our board of directors since August 2002. Mr. Phillips has served as Special Counsel to Medtronic, Inc. since 1999. Mr. Phillips was the Executive Vice President, General Counsel and Secretary of Sofamor Danek Group, Inc., a manufacturer of spinal implants and cranial navigation systems used in neurosurgery, 7 before its acquisition in 1999 by Medtronic. Mr. Phillips serves on the advisory boards of several privately-held companies.